Suppr超能文献

匈牙利新兴的人类肺包虫病(2003-2018 年):一项多中心研究的回顾性病例系列分析。

Emerging human alveolar echinococcosis in Hungary (2003-2018): a retrospective case series analysis from a multi-centre study.

机构信息

Temporarily unaffiliated, Budapest, Hungary.

National Institute of Oncology, Tumour Surgery Centre, Budapest, Hungary.

出版信息

BMC Infect Dis. 2021 Feb 10;21(1):168. doi: 10.1186/s12879-021-05859-5.

Abstract

BACKGROUND

Human alveolar echinococcosis (AE) caused by Echinococcus multilocularis is an underreported, often misdiagnosed and mistreated parasitic disease mainly due to its low incidence. The aim of this study was to describe the epidemiological and clinical characteristics of human AE patients in Hungary for the first time.

METHOD

Between 2003 and 2018, epidemiological and clinical data of suspected AE patients were collected retrospectively from health database management systems.

RESULTS

This case series included a total of 16 AE patients. The mean age of patients was 53 years (range: 24-78 years). The sex ratio was 1:1. Four patients (25%) revealed no recurrence after radical surgery and adjuvant albendazole (ABZ) therapy. For five patients (31.3%) with unresectable lesions, a stabilization of lesions with ABZ treatment was achieved. In seven patients (43.8%), progression of AE was documented. The mean diagnostic delay was 33 months (range: 1-122 months). Three AE related deaths (fatality rate 18.8%) were recorded.

CONCLUSIONS

AE is an emerging infectious disease in Hungary with a high fatality rate since based on our results, almost every fifth AE patient died in the study period. Differential diagnosis and appropriate surgical and medical therapy for AE is an urging challenge for clinicians in Hungary, as well as in some other European countries where E. multilocularis is prevalent.

摘要

背景

由多房棘球绦虫引起的人类泡型包虫病(AE)是一种报道较少、经常误诊和治疗不当的寄生虫病,主要是因为其发病率较低。本研究的目的是首次描述匈牙利人类 AE 患者的流行病学和临床特征。

方法

在 2003 年至 2018 年期间,从健康数据库管理系统中回顾性收集了疑似 AE 患者的流行病学和临床数据。

结果

本病例系列共包括 16 名 AE 患者。患者的平均年龄为 53 岁(范围:24-78 岁)。男女比例为 1:1。4 名患者(25%)在根治性手术和辅助阿苯达唑(ABZ)治疗后无复发。对于 5 名(31.3%)无法切除病变的患者,ABZ 治疗可稳定病变。在 7 名(43.8%)患者中,AE 进展得到证实。平均诊断延迟为 33 个月(范围:1-122 个月)。记录到 3 例 AE 相关死亡(死亡率 18.8%)。

结论

AE 是匈牙利的一种新兴传染病,死亡率很高,因为根据我们的结果,在研究期间,几乎每五名 AE 患者中就有一名死亡。AE 的鉴别诊断以及适当的手术和药物治疗是匈牙利临床医生的紧迫挑战,在一些其他欧洲国家,多房棘球绦虫也很普遍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f354/7877032/f05f9074a323/12879_2021_5859_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验